Providing safe and effective preventative antiretroviral prophylaxis to HIV-exposed newborns via a novel drug delivery system in Tanzania

Pediatric Infectious Disease Journal

Volumn 35, Issue 9, 2016, Pages 987-991

  Dahinten, Alexander P ^a   Dow, Dorothy E ^b,c   Cunningham, Coleen K ^b   Msuya, Levina J ^c   Mmbaga, Blandina T ^c   Malkin, Robert A ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

DBS testing; HIV exposed infants; nevirapine; prevention of mother to child transmission; vertical transmission

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; NUCLEOSIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIAGNOSTIC KIT;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG PACKAGING; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; NEWBORN; OPEN STUDY; PACKAGING MATERIAL; PRENATAL CARE; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SYRINGE; TANZANIA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ANTIBIOTIC PROPHYLAXIS; DIAGNOSTIC KIT; DRIED BLOOD SPOT TESTING; HIV INFECTIONS; INFANT, NEWBORN, DISEASES; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL; TRANSMISSION;

ANTI-HIV AGENTS; ANTIBIOTIC PROPHYLAXIS; DRIED BLOOD SPOT TESTING; DRUG DELIVERY SYSTEMS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REAGENT KITS, DIAGNOSTIC; TANZANIA;

EID: 84969784562     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001224     Document Type: Article

References (25)

1. Tanzanian National Bureau of Statistics, ICF Macro. Tanzania demographic and health survey 2010; 2011. Available at: http://dhsprogram.com/pubs/pdf/FR243/FR243%5B24June2011%5D.pdf. Accessed November 1, 2015
2. Tanzanian Ministry of Health and Social Welfare. HIV/AIDS/STI surveillance report; 2011. Available at: www.nacp.go.tz/site/download/report22.pdf. Accessed November 1, 2015
3. UNAIDS. Gap report [web]; 2014. Available at: http://www.unaids.org/rces/documents/214/040716-UNAIDS-gap-rport. Accessed November 1, 2015
4. Taylor GP, Tamm N, Fidler SJ, et al. Nevirapine clearance after stopping established therapy. In: XIV International AIDS Conference. Barcelona, Spain: International AIDS Society; 2002. Abstract B10472
5. Seyoum D, Primo-Carpenter J. Infant nevirapine dosing for the prevention of mother-To-child transmission in association with timing of maternal intrapartum nevirapine dose: Initiatives of the United States Pharmacopeia Drug Quality and Information Program (USP DQI). In: 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil: Medscape; 2005. Abstract TuPe5.6P01
6. Shetty AK, Coovadia HM, Mirochnick MM, et al.; HIVNET 023 Study Team. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. J Acquir Immune Defic Syndr. 2003; 34: 482-490
7. PATH. Improving delivery of nevirapine for infants; 2006. Available at: http://www.path.org/publications/files/CP-kenya-nvp-fs.pdf. Accessed November 1, 2015
8. Kagaayi J, Dreyfuss ML, Kigozi G, et al. Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda. J Acquir Immune Defic Syndr. 2005; 39: 121-124
9. Sripipatana T, Spensley A, Miller A, et al. Site-specific interventions to improve prevention of mother-To-child transmission of human immunodeficiency virus programs in less developed settings. Am J Obstet Gynecol. 2007; 197(3 suppl): S107-S112
10. Malkin R. A pouch may be prevent the transmission of HIV from mother to child. J Biomed Eng Res. 2013; 2: 66-70
11. Malkin R. Foilized pouches can prevent the transmission of HIV from mother to child using multi-drug therapies. J Biomed Sci Eng. 2014; 7: 45-47
12. Malkin R, Howard C. A foilized polyethylene pouch for the prevention of transmission of HIV from mother to child. Open Biomed Eng J. 2012; 6: 92-97
13. Britt A. Emptying Percentage-Drug Delivery Vehicle Comparison, Senior Thesis. Durham, NC, 2011
14. Choy A, Ortiz M, Malkin R. Accurate dosing of antiretrovirals at home using a foilized, polyethylene pouch to prevent the transmission of HIV from mother to child. Medicine (Baltimore). 2015; 94: e1030
15. Howarda LM, Tiqueb JA, Gavetac S, et al. Health literacy predicts pediatric dosing accuracy for liquid zidovudine. AIDS. 2014: 1041-1048
16. Dahinten AP, Malkin RA. The Pratt pouch provides a three-fold access increase to antiretroviral medication for births outside health facilities in Southern Zambia. Open Biomed Eng J. 2016; 10: 12-18
17. Koal T, Burhenne H, Römling R, et al. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005; 19: 2995-3001
18. Kromdijk W, Mulder JW, Rosing H, et al. Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz. J Antimicrob Chemother. 2012; 67: 1211-1216
19. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; 2013. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/en/. Accessed November 1, 2015
20. Tanzanian Ministry of Health and Social Welfare. Tanzania National Guidelines for Comprehensive Care of PMTCT Services, 3rd ed. 2012. Available at: http://pmtct.or.tz/resource/tanzania-national-guidelines-for-comprehensive-care-ofpmtct-services-3rd-edition/. Accessed November 1, 2015
21. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach; 2010. Available at: http://apps.who.int/iris/bitstr eam/10665/75236/1/9789241599818eng.pdf. Accessed November 1, 2015
22. Cheeseman SH, Hattox SE, McLaughlin MM, et al. Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother. 1993; 37: 178-182
23. Lau E, Brophy J, Samson L, et al. Nevirapine pharmacokinetics in HIVexposed neonates receiving triple combination antiretroviral therapy as post-exposure prohylaxis. In: 6th International Workshop on HIV Pediatrics. Melbourne, Australia: Education V; 2014
24. Mugabo P, Els I, Smith J, et al. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-Tochild transmission of HIV-1. S Afr Med J. 2011; 101: 655-658
25. Nyaruhucha CN, Msuya JM, Ngowi B, et al. Maternal weight gain in second and third trimesters and their relationship with birth weights in Morogoro Municipality, Tanzania. Tanzan Health Res Bull. 2006; 8: 41-44